12.92 USD
▲+1.24+10.62%
盘后 9.26 0.00%
2026-09-16
市值
$133.20M
市盈率
—
EPS
-0.94
股息率
—
52 周区间
6.79 – 41.72
成交量
40.47K
Beta
1.39
目标价
—
52W 低 6.7952W 高 41.72
价格走势
公司简介
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cance...